SCHEMBL26423453

SCHEMBL26423453

c1cnc2oc3nc4cnccc4nc3c2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP3A4 P08684 1/20 0.34
PIK3CA P42336 6/20 0.34
LMNA P02545 1/20 0.33
NPC1 O15118 1/20 0.33
HSP90AA1 P07900 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
LATS1 O95835 1/20 0.33
LATS2 Q9NRM7 1/20 0.33
MAPT P10636 1/20 0.32
F2 P00734 1/20 0.32
IKBKE Q14164 2/20 0.31
TBK1 Q9UHD2 1/20 0.31
PIK3R1 P27986 1/20 0.31
MTOR P42345 1/20 0.31
F7 P08709 1/20 0.31
F3 P13726 1/20 0.31
CLK1 P49759 1/20 0.31
PDPK1 O15530 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26423451 1.00 KDM4E (0.36) KDM4EALDH1A1CYP3A4PIK3CALMNA
SCHEMBL26423369 0.85 KDM4E (0.45) KDM4EALDH1A1CYP3A4PIK3CALMNA
SCHEMBL26423480 0.79 MAPK14 (0.39) KDM4EALDH1A1CYP3A4LMNANPC1
SCHEMBL26423468 0.79 MAPK14 (0.39) KDM4EALDH1A1CYP3A4LMNANPC1
SCHEMBL26423471 0.78 DAGLA (0.32) KDM4EALDH1A1LATS1LATS2F7
SCHEMBL26423473 0.78 DAGLA (0.32) KDM4EALDH1A1LATS1LATS2F7
SCHEMBL26423461 0.76 IDO1 (0.34) KDM4EALDH1A1LATS1LATS2F7
SCHEMBL26423460 0.76 IDO1 (0.34) KDM4EALDH1A1LATS1LATS2F7
SCHEMBL26423457 0.76 KDM4E (0.39) KDM4EALDH1A1CYP3A4PIK3CALMNA
SCHEMBL26423449 0.76 KDM4E (0.39) KDM4EALDH1A1CYP3A4PIK3CALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230127291-A1 HETEROCYCLIC ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY PANEL WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230127291-A1 HETEROCYCLIC ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY PANEL OCIAD2, OCIAD1, AZI2 KDM4E 2800/4885ALDH1A1 302/4885CYP3A4 709/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.